Section 102 Modifications: Israel's "Statutory Silence"

The Gap Between Statute and Reality

Section 102 of the Israeli Income Tax Ordinance is one of Israel's most valuable equity compensation tools. It was designed to define how equity enters a tax-favoured regime, providing a path to a 25% capital gains rate that is a cornerstone of the Israeli tech ecosystem. When a company grants awards, it sets critical terms, such as exercise price, quantity, vesting schedules, and expiration dates.

However, Section 102 is completely silent on one of the most common challenges global companies face: what happens if and when those terms need to be changed following the grant date. Whether driven by market volatility (triggering a need for repricing) or personal employee circumstances (such as departure), the law provides no roadmap for modifications. This "statutory silence" is filled by the Israeli Tax Authority (ITA) through interpretation and positions.

Why Modifications Are Different in Israel

Preserving the preferential tax treatment of Section 102 is a business priority, but it comes with strict conditions, most notably a mandatory two-year statutory holding period. Into the silence of the law steps the ITA with a consistent position: any modification to the terms of an equity award after the grant date constitutes a deemed taxable event. This breaches the holding period: if the holding period has not yet lapsed, the employee loses the beneficial capital gains treatment and faces ordinary income tax.

The ITA's starting point is that if a modification is implemented then it was designated to improve the participant's position, and accordingly an economic benefit is considered to have been conferred - at least on a conceptual level, given that such changes are, by their nature, intended to enhance the employee’s rights or entitlements. The difficulty for the ITA, however, lies in establishing whether a tangible economic benefit has in fact been created, and in accurately measuring its value.

The difficulty for the ITA lies in establishing whether a tangible economic benefit exists at the moment of change and, if so, in accurately measuring its value. A repricing, for example, does not guarantee an immediate gain. To bridge this gap, the ITA allows companies to apply for a tax ruling to determine the specific tax consequences and preserve the award's tax-favoured status under certain conditions. 

The Tax Ruling: Where Decisions Are Made

In light of this inherent difficulty in establishing the existence and extent of a benefit, the ITA has demonstrated a degree of flexibility by allowing companies to seek a tax ruling to clarify the tax implications of a given modification. In that process, the company is required to present the relevant factual background, the specific circumstances of the case, and the nature of the modification. The ITA then reviews the matter on a case-by-case basis to determine whether an immediate tax event may be waived and, instead, a tax arrangement applied to govern the resulting tax consequences.

In some cases, the ITA requires a robust valuation to establish the "fair market value" (FMV) at the time of the modification.

One common example is the repricing of options’ exercise prices. Repricing occurs when options fall "underwater" due to market declines and no longer serve as an incentive. Since a repricing is a modification and since the Israeli tax ordinance lacks a predefined statutory repricing framework, companies seeking certainty must typically pursue a ruling to ensure the new, lower exercise price doesn't disqualify the awards from Section 102 benefits. Without a defensible valuation, the ITA may not be convinced that there is no benefit standing behind the reducing of the exercise price to represent a fair economic value to the options, potentially leading the ITA to point on an immediate tax exposure.

Because the law remains unwritten and practices evolve, flexibility is key. Companies should not look for a one-size-fits-all rulebook but for a strategic path that aligns market needs with the ITA’s current stance.

Re-Grant Treatment: The Deep Impact of a Tax "Reset"

When the ITA agrees to "ignore" the deemed taxable event, it usually applies a "sanction" known as Re-Grant Treatment. This reshapes the taxable impact of the award in several ways:

The Statutory Holding Period Reset

The 24-month Section 102 holding period countdown restarts from the date that is determined by the ITA in the tax ruling as the grant date for tax purposes. If shares are sold before this new clock runs out, the entire award could lose its capital gains eligibility.

Shifting the Ordinary Income Baseline

For public companies, the "benefit component" (i.e. the ordinary income portion of the gain) is calculated based on the 30-day average share price prior to the grant. A Re-Grant shifts this reference point to the 30-day average price prior to the date that is considered by the ITA as the new grant date of the award. If the stock price has risen, a larger portion of future gains is shifted into the higher ordinary income tax bracket, significantly reducing the benefit of the capital gain component for the participant.

Transaction Proximity and Risk Factors

Modifications occurring near certain corporate events carry the highest risk:

• Liquidity Events: Changes made near an M&A or IPO may be viewed as an attempt to circumvent tax and the ITA may apply specific tax arrangements in such regard.
• Employee Terminations: Extending exercise periods during a departure must be assessed carefully, as the ITA may reclassify the benefit as taxable severance pay.

Strategy Within the Statutory Vacuum

The “statutory silence” of Section 102 on modifications does not create a regulatory void. Instead, it creates a landscape where positioning and timing are critical determinants of outcome. Common practice bridges the gap between the market’s need for operational flexibility and the ITA’s positions.

By navigating the complexities of modification baselines, the focus shifts from managing tax "surprises" into making calculated, advance planned, strategic decisions within the Israeli equity landscape.

Note: The information presented herein provides a general overview for information purposes only and does not constitute financial, tax, legal, or any other advice. Parties reviewing the above recognize that each model has distinct, various tax and regulatory implications based on applicable jurisdiction and circumstances. 

For additional insights into global equity compensation, including Israel-specific considerations, see the NASPP blog “Global Stock Compensation: Key Considerations and Resources.”